Cormorant Asset Management LP 13D and 13G filings for Harpoon Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-11-06 4:01 pm Purchase | 2023-10-25 | 13G | Harpoon Therapeutics, Inc. HARP | Cormorant Asset Management LP | 1,678,619 9.900% | 1,678,619 (New Position) | Filing |